Clinical Trial Update: Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by Henan Cancer Hospital evaluating Utidelone in combination with Bevacizumab for HER2-negative advanced breast cancer after …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Utidelone (utidelone)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: HER-2 Negative Breast Cancer | Phase 2 | Status: RECRUITING